Showing results (61-70 of 170) with videos related to
Sort By:
Pageof 17
JHEP Reports : Innovation in Hepatology|June 3, 2024
Enhanced liver fibrosis (ELF) score predicts hepatic decompensation and mortalityMadeline Pearson, Jennifer Nobes, Iain Macpherson, et al.European Journal of Gastroenterology & Hepatology|September 13, 2008
Use of oesophageal stress response proteins as potential biomarkers in the screening for Barrett's oesophagusMaximillian Groome, Jamie Lindsay, Peter E Ross, et al.Plos One|April 16, 2024
Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosisMarc Gurun, Paul Brennan, Sava Handjiev, et al.European Journal of Gastroenterology & Hepatology|January 25, 2003
Alteration of glutathione S-transferase levels in Barrett's metaplasia compared to normal oesophageal epitheliumSarah C Cobbe, Gillian C Scobie, Elizabeth Pohler, et al.Plos One|April 28, 2022
Thrombocytosis and abnormal liver enzymes: A trigger for investigation of underlying malignancyLucy C Gold, Iain Macpherson, Jennifer H Nobes, et al.Psychological Reports|December 3, 2003
Cognitive Testing Battery: differences among groups with dementia, Huntington's disease, and controlsLee Hyer, Steven Sohnle, Michael H Miller, et al.Family Practice|May 15, 2009
Health outcomes following liver function testing in primary care: a retrospective cohort studyDavid J McLernon, Peter T Donnan, Stephen Ryder, et al.Molecular & Cellular Proteomics : MCP|February 18, 2004
The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damageElizabeth Pohler, Ashley L Craig, James Cotton, et al.BMC Health Services Research|April 18, 2007
Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE)Peter T Donnan, David McLernon, Douglas Steinke, et al.Frontline Gastroenterology|October 19, 2023
Exploring changing attitudes to non-invasive liver fibrosis tests in secondary care pathways: comparison of two national surveysKushala W M Abeysekera, Ankur Srivastava, Ian Rowe, et al.Pageof 17